Fraser Witherow

675 total citations
11 papers, 247 citations indexed

About

Fraser Witherow is a scholar working on Surgery, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Fraser Witherow has authored 11 papers receiving a total of 247 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 4 papers in Genetics and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Fraser Witherow's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers), Coronary Interventions and Diagnostics (4 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). Fraser Witherow is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers), Coronary Interventions and Diagnostics (4 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). Fraser Witherow collaborates with scholars based in United Kingdom, Italy and Germany. Fraser Witherow's co-authors include Keith A.A. Fox, David E. Newby, David J. Webb, Ahmed Helmy, Pamela Dawson, Christopher A. Ludlam, Nicholas L. Cruden, David J. Webb, Andrew Davie and Peter O’Kane and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Fraser Witherow

9 papers receiving 240 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fraser Witherow United Kingdom	6	145	77	54	44	28	11	247
JR Cockcroft United Kingdom	5	117 0.8×	73 0.9×	33 0.6×	17 0.4×	9 0.3×	12	221
Denise Cristiana Faro Italy	11	180 1.2×	57 0.7×	29 0.5×	71 1.6×	44 1.6×	22	315
Tomoya Hara Japan	9	176 1.2×	27 0.4×	100 1.9×	68 1.5×	9 0.3×	21	364
Andrzej Kułach Poland	11	136 0.9×	19 0.2×	27 0.5×	61 1.4×	17 0.6×	38	351
Hong‐Mou Shih Taiwan	9	52 0.4×	22 0.3×	61 1.1×	51 1.2×	20 0.7×	15	292
Thomas F. Lüscher Switzerland	10	69 0.5×	12 0.2×	42 0.8×	53 1.2×	24 0.9×	13	271
Sarah Seiler-Mußler Germany	10	52 0.4×	22 0.3×	35 0.6×	38 0.9×	8 0.3×	13	212
Katarzyna Stankowska Poland	8	224 1.5×	27 0.4×	16 0.3×	111 2.5×	10 0.4×	19	359
Gail Berman United States	6	398 2.7×	20 0.3×	132 2.4×	131 3.0×	28 1.0×	7	476
A D Blann United Kingdom	6	121 0.8×	13 0.2×	69 1.3×	61 1.4×	6 0.2×	7	333

Countries citing papers authored by Fraser Witherow

Since Specialization

Citations

This map shows the geographic impact of Fraser Witherow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fraser Witherow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fraser Witherow more than expected).

Fields of papers citing papers by Fraser Witherow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fraser Witherow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fraser Witherow. The network helps show where Fraser Witherow may publish in the future.

Co-authorship network of co-authors of Fraser Witherow

This figure shows the co-authorship network connecting the top 25 collaborators of Fraser Witherow. A scholar is included among the top collaborators of Fraser Witherow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fraser Witherow. Fraser Witherow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Witherow, Fraser, et al.. (2025). A rare presentation of cardiomyopathy associated with Addison's disease: a case report. European Heart Journal - Case Reports. 9(11). ytaf455–ytaf455.

Belder, Adam de, Aung Myat, Jonathan Blaxill, et al.. (2021). Revascularisation or medical therapy in elderly patients with acute anginal syndromes: the RINCAL randomised trial. EuroIntervention. 17(1). 67–74. 39 indexed citations

Wiemer, Marcus, Gian Battista Danzi, Nick E.J. West, et al.. (2015). Drug-eluting stents with biodegradable polymer for the treatment of patients with diabetes mellitus: clinical outcome at 2 years in a large population of patients. Medical Devices Evidence and Research. 8. 153–153. 4 indexed citations

Edwards, Tim, et al.. (2014). Takotsubo cardiomyopathy: a possible metabolic disorder.

Fath‐Ordoubadi, Farzin, Karl-Eugen Hauptmann, Azeem Latib, et al.. (2012). TCT-690 Safety and Clinical Efficacy of Sideguard® Stent for Treatment of Bifurcation Lesions: Interim Results from the European Sideguard® Bifurcation Registry Study. Journal of the American College of Cardiology. 60(17). B201–B201. 1 indexed citations

Sado, Daniel & Fraser Witherow. (2009). Rebuttal: Sterile granuloma formation following radial artery facilitated coronary catheterization. Catheterization and Cardiovascular Interventions. 76(6). 909–910. 2 indexed citations

Cruden, Nicholas L., Fraser Witherow, David J. Webb, Keith A.A. Fox, & David E. Newby. (2004). Bradykinin Contributes to the Systemic Hemodynamic Effects of Chronic Angiotensin-Converting Enzyme Inhibition in Patients With Heart Failure. Arteriosclerosis Thrombosis and Vascular Biology. 24(6). 1043–1048. 38 indexed citations

Witherow, Fraser, Pamela Dawson, Christopher A. Ludlam, et al.. (2003). Bradykinin Receptor Antagonism and Endothelial Tissue Plasminogen Activator Release in Humans. Arteriosclerosis Thrombosis and Vascular Biology. 23(9). 1667–1670. 15 indexed citations

Witherow, Fraser, Pamela Dawson, Christopher A. Ludlam, Keith A.A. Fox, & David E. Newby. (2002). Marked bradykinin-induced tissue plasminogen activator release in patients with heart failure maintained on long-term angiotensin-converting enzyme inhibitor therapy. Journal of the American College of Cardiology. 40(5). 961–966. 40 indexed citations

10.

Witherow, Fraser, Ahmed Helmy, David J. Webb, Keith A.A. Fox, & David E. Newby. (2001). Bradykinin Contributes to the Vasodilator Effects of Chronic Angiotensin-Converting Enzyme Inhibition in Patients With Heart Failure. Circulation. 104(18). 2177–2181. 99 indexed citations

11.

Stewart, Andrew, Fraser Witherow, Pamela Dawson, et al.. (2000). Local and Systemic Effects of Intra-arterial Desmopressin in Healthy Volunteers and Patients with Type 3 von Willebrand Disease. Thrombosis and Haemostasis. 84(8). 195–203. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact